BOSTON – (October 7, 2014) – Lori Laffel, M.D., M.P.H., Chief of Joslin’s clinical programs for Children, Adolescents and Young Adults, and Senior Investigator in the Section on Genetics and Epidemiology, has been promoted by Harvard Medical School to Professor of Pediatrics.

Dr. Laffel has also been very active on the national policy level.  She is a member of the National Committee for Professional Practice Guidelines for the American Diabetes Association (ADA), inaugural Chair of the ADA’s Working Group on Transitions in Care for Young Adults with Diabetes, and past Chair of ADA’s Youth Strategies Committee. She has also been a member of the Advisory Board of the International Society of Pediatric and Adolescent Diabetes (ISPAD) and a member on the Clinical Advisory Committee for the JDRF. 

In 2013 she was the Co-editor on the ADA-JDRF Sourcebook on Type 1 Diabetes through the Lifespan, and this year a co-author of the new “ADA Position Statement on Type 1 Diabetes through the Lifespan.”

Dr. Laffel lectures at undergraduate and graduate levels, and serves as mentor for doctoral students, fellows, and junior faculty. She is an invited speaker at local, national, and international meetings, in areas of pediatric diabetes, childhood obesity, behavioral and outcomes research, and the assessment and translation of new technologies in diabetes. She is Principal Investigator on multiple clinical research projects, with grants from NIH, foundations, and industry. 

She also participates in the peer-review process for journals and funding organizations locally, nationally, and internationally, reviewing for NIH, JDRF, the French Inserm, the German Research Foundation, Health Research Council of New Zealand, Diabetes UK, and the Dutch Diabetes Research Foundation, among others. She is also an Associate Editor for “Diabetic Medicine.”

Dr. Laffel received her medical degree from the University of Miami School of Medicine, and her master’s degree in Public Health from the Harvard School of Public Health. She completed her pediatric training at Boston Children’s Hospital and her fellowship training at Boston Children’s Hospital and the Joslin Diabetes Center.

###  

Related Articles

A Scientist working in lab
Type 1
Kidney Disease
Research Highlights

The Preventing Early Renal Loss in Diabetes (PERL) Study Conclusion

The Preventing Early Renal Loss in Diabetes (PERL) Study Conclusion

Three-year clinical trial finds reducing uric acid levels in type 1 diabetes provides no beneficial impact on the progression of diabetic kidney disease BOSTON – (November 8, 2019) – Diabetic kidney...
Read more on The Preventing Early Renal Loss in Diabetes (PERL) Study Conclusion
National Diabetes Month
Type 1
Type 2

National Diabetes Awareness Month

National Diabetes Awareness Month

Diabetes is growing at an epidemic rate in the United States and across the globe. According to the Centers for Disease Control and Prevention (CDC), over 30 million Americans have diabetes and 1.5...
Read more on National Diabetes Awareness Month
Red blood cell traveling in an artery
Type 1
Heart Disease
Research Highlights

Research may show way to minimize complications after heart treatment

Research may show way to minimize complications after heart treatment

BOSTON – (October 1, 2019) – People with diabetes are much more likely to develop heart disease than those without the condition. They also are several times more likely to develop complications after...
Read more on Research may show way to minimize complications after heart treatment